Indaptus Therapeutics (NASDAQ:INDP) Releases Earnings Results, Beats Estimates By $0.07 EPS
Indaptus Therapeutics (NASDAQ:INDP – Get Free Report) issued its quarterly earnings results on Monday. The company reported ($0.47) EPS for the quarter, topping analysts’ consensus estimates of ($0.54) by $0.07, Zacks reports. Indaptus Therapeutics Stock Performance Shares of NASDAQ:INDP traded up $0.01 during mid-day trading on Wednesday, reaching $1.68. 3,399 shares of the company’s stock […]
More Stories
Valence8 US LP Takes $268,000 Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Valence8 US LP bought a new position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) during the third quarter, Holdings...
Valence8 US LP Takes $268,000 Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Valence8 US LP bought a new position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) during the third quarter, Holdings...
Martin Marietta Materials, Inc. (NYSE:MLM) Stock Position Cut by Lathrop Investment Management Corp
Lathrop Investment Management Corp decreased its position in Martin Marietta Materials, Inc. (NYSE:MLM – Free Report) by 2.5% in the...
Martin Marietta Materials, Inc. (NYSE:MLM) Stock Position Cut by Lathrop Investment Management Corp
Lathrop Investment Management Corp decreased its position in Martin Marietta Materials, Inc. (NYSE:MLM – Free Report) by 2.5% in the...
AlphaCore Capital LLC Acquires 189 Shares of Blackstone Inc. (NYSE:BX)
AlphaCore Capital LLC increased its holdings in Blackstone Inc. (NYSE:BX – Free Report) by 1.6% in the 3rd quarter, according...
AlphaCore Capital LLC Acquires 189 Shares of Blackstone Inc. (NYSE:BX)
AlphaCore Capital LLC increased its holdings in Blackstone Inc. (NYSE:BX – Free Report) by 1.6% in the 3rd quarter, according...